ESC 365 - Plasma amyloid-beta levels and risk of new-onset atrial fibrillation in the general population

ESC Professional Premium Access

Plasma amyloid-beta levels and risk of new-onset atrial fibrillation in the general population

Session: When is the time to implement novel biomarkers routinely?

Topic: Biomarkers

Speaker: Doctor Z. Lu (Beijing, CN)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Zuolin Lu

Chinese Academy of Medical Sciences, Beijing (China)

0 follower

3 more presentations in this session

State of the art lecture - when is the time to implement novel biomarkers routinely?

Speaker: Professor B. Ference (Cambridge, GB)

Association of fatal and non-fatal adverse health outcomes with urinary peptides reflecting collagen I turnover

Speaker: Doctor J. Melgarejo (Leuven, BE)

Panel discussion.

Access the full session

When is the time to implement novel biomarkers routinely?

Speakers: Doctor Z. Lu, Professor B. Ference, Doctor J. Melgarejo

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources